Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Otsuka Holdings Co ( (JP:4578) ) has shared an update.
Otsuka Holdings has reported progress on a previously approved share repurchase program, buying back 499,800 common shares for approximately ¥5.14 billion on the Tokyo Stock Exchange between March 1 and March 31, 2026. These purchases form part of a broader board-authorized plan, allowing up to 7 million shares and ¥50 billion in buybacks through December 23, 2026, aimed at capital efficiency and shareholder returns.
As of March 31, 2026, total repurchases under this authorization have reached 812,700 shares at an aggregate cost of about ¥8.44 billion, indicating a gradual execution of the program in the early months. The ongoing buyback activity may support earnings per share, signal management’s confidence in the company’s valuation, and potentially enhance shareholder value through reduced share count if the plan continues at a similar pace.
The most recent analyst rating on (JP:4578) stock is a Buy with a Yen13200.00 price target. To see the full list of analyst forecasts on Otsuka Holdings Co stock, see the JP:4578 Stock Forecast page.
More about Otsuka Holdings Co
Otsuka Holdings Co., Ltd. is a Japan-based pharmaceutical and healthcare company listed on the Prime Market of the Tokyo Stock Exchange under code 4578. The group is engaged in the development, manufacturing, and sale of pharmaceuticals and related healthcare products, serving domestic and international markets with a focus on innovative therapies and wellness solutions.
Average Trading Volume: 1,300,536
Technical Sentiment Signal: Buy
Current Market Cap: Yen5932.3B
For detailed information about 4578 stock, go to TipRanks’ Stock Analysis page.